Cohen & Steers, Inc.
CNSFinancial ServicesNASDAQAsset Management
Scan Results
Daily timeframeCohen & Steers, Inc. is a publicly owned asset management holding company. At a $4.11B market cap, Cohen & Steers, Inc. ranks as a mid-cap company within financial services. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations.
Market Cap
$4.11B
Beta
1.20
P/E (TTM)
24.59
P/E (Fwd)
20.09
EPS (TTM)
$3.25
EPS (Fwd)
$3.98
ROE
27.3%
ROA
14.5%
Cash
$282.6M
Total Debt
$134.4M
Free CF
$156.9M
52W Change
13.3%
Annual Financials
Cash vs Debt
Where CNS stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, CNS finished 8.45% above its 150-day moving average ($71.21) and 11.98% above its 200-day moving average ($68.97). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CNS overbought or oversold?
At the September 3, 2026 close, CNS's RSI(14) was 19.9, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $282.6M in cash and $134.4M in debt, CNS maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $156.9M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 27.3% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 14.5% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $573.7M (2022) to $578.1M (2025).
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CNS.